Organ-on-a-Chip Technology: Engineering Human Organs | Dan Huh | TEDxPenn

Added:

Systemic Complexity and Material Limitations of Organ-on-a-Chip Systems

While organ-on-a-chip (OOC) technology offers valuable high-resolution models of specific human tissues, critics and researchers emphasize several limitations that prevent it from fully replacing traditional in vivo models. A primary concern is physiological reductionism: OOC systems struggle to replicate the systemic complexity of a whole living organism, including full-body immune responses, endocrine feedback loops, and multi-organ metabolic interactions. Additionally, technical challenges undermine their reliability. For instance, polydimethylsiloxane (PDMS)—the polymer most commonly used to manufacture these chips—notoriously absorbs small hydrophobic molecules and therapeutic drugs, which can severely skew drug concentration and toxicity data. Furthermore, standardizing these highly specialized platforms for mass production and achieving regulatory acceptance remains a major hurdle. Consequently, many experts argue that while OOC is a powerful complementary tool for early-stage screening, it cannot yet match the holistic predictive power of complex biological organisms.

Basic cellular biology and tissue architecture, including how different human cells interact with each other and their extracellular matrix.
The traditional pipeline of pharmaceutical drug discovery, specifically the high costs, attrition rates, and limitations of animal testing.
Fundamental principles of microfluidics, which involve the behavior and precise control of fluids constrained to a sub-millimeter scale.
Multi-organ-on-a-chip (or body-on-a-chip) systems designed to model systemic drug absorption, distribution, metabolism, and excretion (ADME).
The integration of patient-specific induced pluripotent stem cells (iPSCs) with microfluidic chips to advance personalized medicine.
Regulatory affairs and validation standards required by agencies like the FDA to accept organ-chip data as alternatives to preclinical animal testing.
Advanced biofabrication techniques, such as 3D bioprinting, to create highly complex vascularized tissue models on microfluidic platforms.
57.4K views950likes16:19@TEDxOriginal Release: 2015-06-09

Organ-on-a-chip technology uses microfabrication techniques to create microengineered devices that can grow human cells and mimic the structure and environment of living human organs, such as lungs and eyes, allowing researchers to test drug responses in a more realistic and predictive model than traditional cell culture or animal testing, thereby potentially reducing the time and cost of drug development.